Detalhe da pesquisa
1.
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.
Int J Cancer
; 155(2): 282-297, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489486
2.
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Acta Oncol
; 63: 213-219, 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647024
3.
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Acta Oncol
; 63: 379-384, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779911
4.
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Acta Oncol
; 63: 385-391, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779910
5.
Distribution and characteristics of malignant tumours by lung lobe.
BMC Pulm Med
; 24(1): 106, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439038
6.
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer.
Acta Oncol
; 62(12): 1642-1648, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801361
7.
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
J Transl Med
; 20(1): 225, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568909
8.
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
J Transl Med
; 19(1): 232, 2021 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059094
9.
Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
BMC Cancer
; 21(1): 1089, 2021 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625038
10.
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.
Acta Oncol
; 60(2): 149-156, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356733
11.
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.
Acta Oncol
; 60(12): 1565-1571, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486915
12.
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy.
Int J Cancer
; 147(10): 2957-2966, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468587
13.
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases.
Scand J Immunol
; 92(2): e12893, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433774
14.
Antibody combinations for optimized staining of macrophages in human lung tumours.
Scand J Immunol
; 92(1): e12889, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299134
15.
A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.
J Mammary Gland Biol Neoplasia
; 24(2): 163-175, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613869
16.
Increase in curative treatment and survival of lung cancer in Norway 2001-2016.
Eur J Epidemiol
; 34(10): 951-955, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313073
17.
Hever kvaliteten på behandling av kreft.
Tidsskr Nor Laegeforen
; 144(1)2024 01 23.
Artigo
em Norueguês
| MEDLINE | ID: mdl-38258713
18.
Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.
BMC Cancer
; 18(1): 739, 2018 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005623
19.
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab.
Acta Oncol
; 57(9): 1225-1231, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29683761
20.
New centres to carry out more clinical trials in Norway. / Nye sentre skal gi flere kliniske studier i Norge.
Tidsskr Nor Laegeforen
; 143(2)2023 01 31.
Artigo
em Inglês, Norueguês
| MEDLINE | ID: mdl-36718905